Clinical Trial Update: Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating Benmelstobart in combination with radiochemotherapy as neoadjuvant treatment for Esophageal squamous cell carcinoma; recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Benmelstobart

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: RECRUITING